FDA to discuss Novartis' TOBI Podhaler

FDA's Anti-Infectives Drugs Advisory Committee will meet on Sept. 5 to discuss an NDA from Novartis AG (NYSE:NVS; SIX:NOVN) for TOBI Podhaler to treat Pseudomonas aeruginosa lung infections in cystic...